Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

Seligson & Co Global Top 25 Pharmac.

+ Add to Watchlist

SEL25PB:FH

15.56 EUR 0.000.00%

As of 01:59:30 ET on 05/22/2015.

Snapshot for Seligson & Co Global Top 25 Pharmac. (SEL25PB)

Year To Date: +18.71% 3-Month: +3.10% 3-Year: +27.79% 52-Week Range: 10.93 - 16.16
1-Month: -1.71% 1-Year: +42.52% 5-Year: +21.67% Beta vs HEXP: 0.68

Mutual Fund Chart for SEL25PB

No chart data available.
  • SEL25PB:FH 15.58
  • 1M
  • 1Y
Interactive SEL25PB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SEL25PB

Seligson & Co Global Top 25 Pharmaceuticals is an open-end fund incorporated in Finland. The Fund's objective is a return that follows the return of the world's top 25 pharmaceutical companies. The Fund invests in a basket of equities of the world's top 25 pharmaceutical companies.

Inception Date: 01-15-2000 Telephone: 358-9-6817-8200
Managers: JANI HOLMBERG / JAANA TIMONEN
Web Site: www.seligson.fi

Fundamentals for SEL25PB

NAV (on 2015-05-27) 15.58
Assets (M) (on 2015-04-30) 223.44
Fund Leveraged N
Minimum Investment 1.00
Minimum Subsequent Investment 1.00

Dividends for SEL25PB

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for SEL25PB

Front Load 0.00
Back Load 0.50
Current Mgmt Fee 0.50
Redemption Fee 0.50
12b1 Fee -
Expense Ratio 0.61

Top Fund Holdings for SEL25PB

Filing Date: 04/30/2015
Name Position Value % of Total
Novartis AG 162,817 14,922,239 6.678%
Pfizer Inc 475,549 14,530,546 6.503%
Roche Holding AG 55,851 14,216,425 6.363%
Johnson & Johnson 149,055 13,339,087 5.970%
Merck & Co Inc 250,154 13,307,060 5.956%
Daiichi Sankyo Co Ltd 572,400 8,945,761 4.004%
Novo Nordisk A/S 177,331 8,779,210 3.929%
Takeda Pharmaceutical Co Ltd 178,800 8,251,792 3.693%
Shire PLC 110,600 7,999,697 3.580%
Sanofi 86,720 7,853,363 3.515%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil